Primary record
(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoic acid
- 库存
- 3,838 克
- 纯度
- 99.3 %
- CAS
- 36150-01-3
化合物标识与属性
- CAS
- 36150-01-3
- PubChem CID
- 5283078
- SMILES
- CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C/CCCC(=O)O)O)O)O
- Canonical SMILES
- CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C/CCCC(=O)O)[C@@H](O)C[C@H]1O
名称与同义词
- 5-trans-PGF2alpha
- dinoprost
- Prostaglandin F2a
- 5-Trans Prostaglandin F2alpha
- amoglandin
- cyclosin
- panacelan
- Dinifertin
- Prostamate
- Protamodin
- Enzaprost
- Prostarmon F
- Enzaprost F
- F2a Isoprostane
- Glandin N
- Prostaglandin F2
- 5,6-trans-Pgf2alpha
- EM5T9R5FAS
- l-PGF2-alpha
- Prostin F 2 alpha
- 5-trans-Prostaglandin F2alpha
- PGF2a
- UNII-EM5T9R5FAS
- 5,6-trans PGF2alpha
- (+)-Prostaglandin F2a
- RefChem:103459
- 5-trans-PGF2I+/-
- l-Prostaglandin F2-alpha
- 36150-01-3
- 5-trans Prostaglandin F2
- 9a,11a-PGF2a
- 5-Isoprostagrandin F2alpha
- 5-TRANS-PGF2.ALPHA.
- 5,6-trans-Prostaglandin F2alpha
- AC1NR1H4
- 9a,11a-PGF2
- 5-TRANS PROSTAGLANDIN F2|A
- 5,6-TRANS-PGF2.ALPHA.
- SCHEMBL9444033
- 5-trans Prostaglandin F2 alpha
- 5-trans Prostaglandin F2.|A.
- C20H34O5
- CHEBI:187232
- Dinoprost trometamol impurity A [EP]
- PXGPLTODNUVGFL-UAAPODJFSA-N
- DTXSID501317801
- HMS3648P21
- Dinoprost Trometamol EP Impurity A
- 1464AH
- 5-TRANS-PROSTAGLANDIN F2.ALPHA.
- LMFA03010077
- MFCD00135233
- PDSP2_001535
- ZINC12494893
- 5,6-TRANS-PROSTAGLANDIN F2.ALPHA.
- CID5283078
- HY-129953A
- NCGC00344182-03
- PD021088
- 9S,11R,15S-trihydroxy-5E,13E-prostadienoic acid
- LS-187223
- (E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid
- AB00514670
- CS-0133871
- J1.068.163D
- DINOPROST TROMETAMOL IMPURITY A [EP IMPURITY]
- H49723
- 9,11,15-trihydroxyprosta-5Z,13E-dien-1-oate
- SR-01000946472
- 9,11,15-trihydroxyprosta-5Z,13E-dien-1-oic acid
- SR-01000946472-1
- DINOPROST TROMETAMOL IMPURITY A (EP IMPURITY)
- Q63398817
- (5E,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid
- 9a,11a,15(S)-Trihydroxy-5-cis-13-trans-prostadienoate
- Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5E,9alpha,11alpha,13E,15S)-
- (9alpha,11alpha,15)-trihydroxyprosta-(5Z,13E)-dien-1-oate
- 551-11-1
- 9a,11a,15(S)-Trihydroxy-5-cis-13-trans-prostadienoic acid
- (5E,9.ALPHA.,11.ALPHA.,13E,15S)-9,11,15-TRIHYDROXYPROSTA-5,13-DIEN-1-OIC ACID
- (5Z,13E,15S)-9a,11a,15-trihydroxyprosta-5,13-dien-1-oate
- (5Z,13E,15S)-9a,11a,15-trihydroxyprosta-5,13-dien-1-oic acid
- (9alpha,11alpha,15)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid
- 7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoate
- (5E,13E,15S)-9alpha,11alpha,15-Trihydroxyprosta-5,13-dien-1-oic acid
- (5E,13E,15S)-9alpha,11alpha,15-Trihydroxyprosta-5,13-diene-1-oic acid
- (5z,13e)-(15s)-9-alpha,11-alpha,15-trihydroxyprosta-5,13-dienoate
- (5Z,13E)-(15S)-9-alpha,11-alpha,15-trihydroxyprosta-5,13-dienoic acid
- (5Z,9a,11a,13E,15S)-9,11,15-trihydroxy-Prosta-5,13-dien-1-oate
- (5Z,9a,11a,13E,15S)-9,11,15-trihydroxy-Prosta-5,13-dien-1-oic acid
- 7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid
- 9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-oate
- 9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-oic acid
- 9ALPHA,11ALPHA,15S-TRIHYDROXY-PROSTA-5E,13E-DIEN-1-OIC ACID
- PROSTA-5,13-DIEN-1-OIC ACID, 9,11,15-TRIHYDROXY-, (5E,9.ALPHA.,11.ALPHA.,13E,15S)-
- (5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoic acid
- (E)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)cyclopentyl)hept-5-enoic acid
- (E)-7-[(1R,2R,3R,5S)-2-[(1E,3S)-3-Hydroxy-1-octenyl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid